Alseres Pharmaceuticals Inc (ALSE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2011 | 09-2011 | 06-2011 | 03-2011 | 12-2010 | |
| Operating Expenses | 337 | 537 | 68 | 623 | 226 |
| Operating Income | -337 | -537 | -68 | -623 | -226 |
| Interest Expense | 444 | 476 | 465 | 454 | 594 |
| Other Income | -15 | 536 | 0 | 0 | 1 |
| Pre-tax Income | -795 | -477 | -534 | -1,077 | -818 |
| Net Income Continuous | -795 | -477 | -534 | -1,077 | -818 |
| Net Income | $-795 | $-477 | $-534 | $-1,077 | $-818 |
| EPS Basic Total Ops | -100.00 | -100.00 | -100.00 | -200.00 | -50.00 |
| EPS Basic Continuous Ops | -115.93 | -75.28 | -94.26 | -200.97 | -129.92 |
| EPS Diluted Total Ops | -100.00 | -100.00 | -100.00 | -200.00 | N/A |
| EPS Diluted Continuous Ops | -115.93 | -75.28 | -94.26 | -200.97 | -7.86 |
| EBITDA(a) | $-336 | $-524 | $-51 | $-607 | $-209 |